Transcatheter Embolization and Occlusion Devices Market by Product - Global Industry Analysis and Forecast to 2023

Published On : March 2018 Pages : 90 Category: Medical Devices Report Code : HC03625

Industry Outlook and Trend Analysis

The Transcatheter Embolization and Occlusion Devices Market was worth USD 2.34 billion in 2014 and is expected to reach approximately USD 5.29 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.50% during the forecast period. The market is observing significant development in the course of the most recent decade. The change in perspective from clipping to coiling has invigorated the interest for transcatheter embolization devices. Rising demand of embolization strategies in the treatment of cancer is basically boosting the TEO market development. Minimally invasive surgery is another main consideration decidedly affecting the worldwide business. Commercially accessible embolization products, for example, fluid embolic and embolization particles bolster minimally invasive surgeries. Minimally invasive surgeries lessen recuperating time and surgical injuries.

Product Outlook and Trend Analysis

Coils and non-coils are the two kinds of embolization gadgets financially accessible. Coiling being one of the oldest methods is generally embraced by healthcare professionals comprehensively. In addition, accessibility of a wide scope of coils in different shapes and sizes additionally makes the system more positive for various cases. Pushable coils represented the biggest share of around 56% of every 2014 inferable from high awareness with respect to the product. Nonetheless, disadvantages related with pushable coils , for example, the likelihood of being trapped in sharp curves of the veins, trouble in repositioning once sent, and plausibility of getting stuck in catheters are seen to hinder its selection.

Regional Outlook and Trend Analysis

North America and Europe together represented the largest share of the overall industry of around 58% in 2014. The existence of well-defined regulatory framework, propelled social insurance framework, and experienced medicinal services experts to play out the strategies are a portion of the elements encountered to fuel interest for TEO in these areas. Asia Pacific is foreseen to develop at the speediest CAGR amid the estimate time frame.

Competitive Insights

The leading players in the market are St. Jude Medical, DePuy Synthes Companies, Medtronic, Cook Group, Stryker Corporation, Terumo Corporation, Cordis Corporation, Sirtex Medical and Boston Scientific. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Transcatheter Embolization and Occlusion Devices Market is segmented as follows-

By Product:

  • Coils
    • Detachable Coils
    • Pushable Coils
  • Non-Coils
    • Embolization Particles
    • Liquid Embolics
    • Flow Diverting Devices
    • Other Embolization and Occlusion Devices
    • Accessories

By Region

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2023?
  • What will be the industry market growth from 2015 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Transcatheter Embolization and Occlusion Devices Market, By Product, Estimates and Forecast, 2014-2023($Million)

·         Coil

o    Pushable Coils

o    Detachable Coils

·         Non Coil

o    Flow Diverting Devices

o    Embolization Particles

o    Liquid Embolics

o    Other Embolization and Occlusion Devices

o    Accessories

·         Transcatheter Embolization and Occlusion Devices Market, By Region, Estimates and Forecast, 2014-2023($Million)

o    North America

§  North America Transcatheter Embolization and Occlusion Devices Market , By Country

§  North America Transcatheter Embolization and Occlusion Devices Market , By Product

o    U.S. Transcatheter Embolization and Occlusion Devices Market , By Product

o    Canada Transcatheter Embolization and Occlusion Devices Market , By Product

o    Mexico Transcatheter Embolization and Occlusion Devices Market , By Product

o    Europe

§  Europe Transcatheter Embolization and Occlusion Devices Market , By Country

§  Europe Transcatheter Embolization and Occlusion Devices Market , By Product

o    Germany Transcatheter Embolization and Occlusion Devices Market , By Product

o    France Transcatheter Embolization and Occlusion Devices Market , By Product

o    UK Transcatheter Embolization and Occlusion Devices Market , By Product

o    Italy Transcatheter Embolization and Occlusion Devices Market , By Product

o    Spain Transcatheter Embolization and Occlusion Devices Market , By Product

o    Rest of Europe Transcatheter Embolization and Occlusion Devices Market , By Product

o    Asia-Pacific

§  Asia-Pacific Transcatheter Embolization and Occlusion Devices Market , By Country

§  Asia-Pacific Transcatheter Embolization and Occlusion Devices Market , By Product

o    Japan Transcatheter Embolization and Occlusion Devices Market , By Product

o    Australia Transcatheter Embolization and Occlusion Devices Market , By Product

o    India Transcatheter Embolization and Occlusion Devices Market , By Product

o    South Korea Transcatheter Embolization and Occlusion Devices Market , By Product

o    Rest of Asia-Pacific Transcatheter Embolization and Occlusion Devices Market , By Product

o    Rest of the World

§  Rest of the World Transcatheter Embolization and Occlusion Devices Market , By Country

§  Rest of the World Transcatheter Embolization and Occlusion Devices Market , By Product

o    Brazil Transcatheter Embolization and Occlusion Devices Market , By Product

o    South Africa Transcatheter Embolization and Occlusion Devices Market , By Product

o    Saudi Arabia Transcatheter Embolization and Occlusion Devices Market , By Product

o    Turkey Transcatheter Embolization and Occlusion Devices Market , By Product

o    United Arab Emirates Transcatheter Embolization and Occlusion Devices Market , By Product

o    Others Transcatheter Embolization and Occlusion Devices Market , By Product

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.1.1.    Rising Demand in End-User Industries

3.2.2.  Restraints

3.2.2.1.    Volatile Raw Material Prices

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Transcatheter Embolization and Occlusion Devices Market, By Product

4.1.       Introduction

4.2.       Global Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share by Product (2014-2017)

4.2.1.  Global Transcatheter Embolization and Occlusion Devices Sales and Sales Share by Product (2014-2017)

4.2.2.  Global Transcatheter Embolization and Occlusion Devices Revenue and Revenue Share by Product (2014-2017)

4.3.       Transcatheter Embolization and Occlusion Devices Market  Assessment and Forecast, By Product, 2014-2023

4.4.       Coil

4.4.1.  Market Assessment and Forecast, By Type, 2014-2023($Million)

4.4.2.  Market Assessment and Forecast, By Region, 2014-2023($Million)

4.4.3.  Pushable Coils

4.4.3.1.    Market Assessment and Forecast, By Region, 2014-2023($Million)

4.4.4.  Detachable Coils

4.4.4.1.    Market Assessment and Forecast, By Region, 2014-2023($Million)

4.5.       Non Coil

4.5.1.  Market Assessment and Forecast, By Type, 2014-2023($Million)

4.5.2.  Market Assessment and Forecast, By Region, 2014-2023($Million)

4.5.3.  Flow Diverting Devices

4.5.3.1.    Market Assessment and Forecast, By Region, 2014-2023($Million)

4.5.4.  Embolization Particles

4.5.4.1.    Market Assessment and Forecast, By Region, 2014-2023($Million)

4.5.5.  Liquid Embolics

4.5.5.1.    Market Assessment and Forecast, By Region, 2014-2023($Million)

4.5.6.  Other Embolization and Occlusion Devices

4.5.6.1.    Market Assessment and Forecast, By Region, 2014-2023($Million)

4.5.7.  Accessories

4.5.7.1.    Market Assessment and Forecast, By Region, 2014-2023($Million)

5.       Transcatheter Embolization and Occlusion Devices Market , By Region

5.1.       Introduction

5.2.       Transcatheter Embolization and Occlusion Devices Market   Assessment and Forecast, By Region, 2014-2023($Million)

5.3.       Global Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share by Regions

5.3.1.  Global Transcatheter Embolization and Occlusion Devices Sales by Regions (2014-2017)

5.3.2.  Global Transcatheter Embolization and Occlusion Devices Revenue by Regions (2014-2017)

5.4.       North America

5.4.1.  North America Transcatheter Embolization and Occlusion Devices Sales and Growth Rate (2014-2017)

5.4.2.  Market Assessment and Forecast, By Country, 2014-2023($Million)

5.4.3.  Market Assessment and Forecast, By Product, 2014-2023($Million)

5.4.4.  U.S.

5.4.4.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.4.5.  Canada

5.4.5.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.4.6.  Mexico

5.4.6.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.5.       Europe

5.5.1.  Europe Transcatheter Embolization and Occlusion Devices Sales and Growth Rate (2014-2017)

5.5.2.  Market Assessment and Forecast, By Country, 2014-2023($Million)

5.5.3.  Market Assessment and Forecast, By Product, 2014-2023($Million)

5.5.4.  Germany

5.5.4.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.5.5.  France

5.5.5.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.5.6.  UK

5.5.6.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.5.7.  Italy

5.5.7.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.5.8.  Spain

5.5.8.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.5.9.  Rest of Europe

5.5.9.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.6.       Asia-Pacific

5.6.1.  Asia-Pacific Transcatheter Embolization and Occlusion Devices Sales and Growth Rate (2014-2017)

5.6.2.  Market Assessment and Forecast, By Country, 2014-2023($Million)

5.6.3.  Market Assessment and Forecast, By Product, 2014-2023($Million)

5.6.4.  Japan

5.6.4.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.6.5.  China

5.6.5.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.6.6.  Australia

5.6.6.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.6.7.  India

5.6.7.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.6.8.  South Korea

5.6.8.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.6.9.  Rest of Asia-Pacific

5.6.9.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.7.       Rest of the World

5.7.1.  Rest of the World Transcatheter Embolization and Occlusion Devices Sales and Growth Rate (2014-2017)

5.7.2.  Market Assessment and Forecast, By Country, 2014-2023($Million)

5.7.3.  Market Assessment and Forecast, By Product, 2014-2023($Million)

5.7.4.  Brazil

5.7.4.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.7.5.  Turkey

5.7.5.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.7.6.  Saudi Arabia

5.7.6.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.7.7.  South Africa

5.7.7.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.7.8.  United Arab Emirates

5.7.8.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

5.7.9.  Others

5.7.9.1.    Market Assessment and Forecast, By Product, 2014-2023($Million)

6.       Company Profiles

6.1.       Boston Scientific Corporation

6.1.1.  Business Overview

6.1.2.  Product Portfolio

6.1.3.  Strategic Developments

6.1.4.  Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share

6.2.        Terumo Corporation

6.2.1.  Business Overview

6.2.2.  Product Portfolio

6.2.3.  Strategic Developments

6.2.4.  Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share

6.3.       Medtronic, Inc.

6.3.1.  Business Overview

6.3.2.  Product Portfolio

6.3.3.  Strategic Developments

6.3.4.  Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share

6.4.       Merit Medical System

6.4.1.  Business Overview

6.4.2.  Product Portfolio

6.4.3.  Strategic Developments

6.4.4.  Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share

6.5.       DePuy Synthes

6.5.1.  Business Overview

6.5.2.  Product Portfolio

6.5.3.  Strategic Developments

6.5.4.  Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share

6.6.       Stryker Corporation

6.6.1.  Business Overview

6.6.2.  Product Portfolio

6.6.3.  Strategic Developments

6.6.4.  Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share

6.7.       Cordis Corporation

6.7.1.  Business Overview

6.7.2.  Product Portfolio

6.7.3.  Strategic Developments

6.7.4.  Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share

6.8.       St. Jude Medical

6.8.1.  Business Overview

6.8.2.  Product Portfolio

6.8.3.  Strategic Developments

6.8.4.  Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share

6.9.       Pfizer, Inc.

6.9.1.  Business Overview

6.9.2.  Product Portfolio

6.9.3.  Strategic Developments

6.9.4.  Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share

6.10.    Sirtex medical

6.10.1.      Business Overview

6.10.2.      Product Portfolio

6.10.3.      Strategic Developments

6.10.4.      Transcatheter Embolization and Occlusion Devices Sales, Revenue and Market Share

7.       Global Transcatheter Embolization and Occlusion Devices Market  Competition, by Manufacturer

7.1.       Global Transcatheter Embolization and Occlusion Devices Sales and Market Share by Manufacturer (2016-2017)

7.2.       Global Transcatheter Embolization and Occlusion Devices Revenue and Market Share by Manufacturer (2016-2017)

7.3.       Top 5 Transcatheter Embolization and Occlusion Devices Manufacturer Market Share

7.4.       Market Competition Trend

List of Tables and Figures

*You can glance through the list of Tables and Figures when you view the sample copy of Transcatheter Embolization and Occlusion Devices Market.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*